COMPANY Data
Companies by Sector
More than 6000 listed
My FAVORITES
Company
Price $
+/- %
Movers and SHAKERS
Gevo Reports Second Quarter 2021 Financial Results

Gevo Reports Second Quarter 2021 Financial Results

 

ENGLEWOOD, Colo., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) today announced financial results for the second quarter of 2021 and recent corporate highlights.

Recent Corporate Highlights

  • On August 9, 2021, Gevo announced that its wholly-owned renewable natural gas (“RNG”) project company, Gevo NW Iowa RNG, LLC (“Gevo RNG”), has signed binding, definitive agreements with BP Canada Energy Marketing Corp. and BP Products North America Inc. for the sale of RNG. The RNG project is on schedule and on budget with an anticipated startup early 2022. Beginning in late 2022, Gevo RNG expects to generate cash distributions to Gevo of approximately $9 to $16 million per year.

  • On August 2, 2021, Gevo announced the appointment of Jaime Guillen to its Board of Directors. Mr. Guillen is a Managing Partner at Faros Infrastructure Partners LLC, an investment firm with offices in the United Kingdom, the United States and Mexico.
  • On April 15, 2021, Gevo closed the offering of $68,155,000 in 2021 Bonds to finance the construction of its renewable natural gas project in Iowa.

2021 Second Quarter Financial Highlights

  • Ended the quarter with cash, cash equivalents, restricted cash and marketable securities totaling $567.2 million compared to $525.3 as of the end of Q1 2021 and $6.3 million as of the end of Q2 2020
  • Revenue of $0.4 million for the quarter compared to $1.0 million in Q2 2020
  • Loss from operations (which includes $5.5 million of preliminary stage project costs for Net-Zero 1) of ($19.0) million for the quarter compared to ($5.3) million in Q2 2020
  • Non-GAAP cash EBITDA loss of ($17.1) million for the quarter compared to ($3.1) million in Q2 2020
  • Net loss per share of ($0.09) for the quarter compared to ($0.40) in Q2 2020
  • Non-GAAP adjusted net loss per share of ($0.09) for the quarter compared to ($0.39) in Q2 2020

Commenting on the second quarter of 2021 and recent corporate events, Dr. Patrick R. Gruber, Gevo’s Chief Executive Officer, said “The engineering and design work for our Net-Zero 1 Project is going well. We are figuring out the optimizations and integrations for Net-Zero 1, and how to generate more cash sooner. We are looking forward to completing the next phase of the engineering work in December of this year and moving forward towards getting the financing closed in the first half of next year.”

Second Quarter 2021 Financial Results

Revenue for the three months ended June 30, 2021 was $0.4 million compared with $1.0 million in the same period in 2020.

During the three months ended June 30, 2021, hydrocarbon revenue was $0.3 million compared with $0.9 million in the same period in 2020. Hydrocarbon sales decreased because of lower production volumes at Gevo’s demonstration plant at the South Hampton Resources, Inc. facility in Silsbee, Texas (the “South Hampton Facility”). Gevo’s hydrocarbon revenue is comprised of sales of sustainable aviation fuel and renewable premium gasoline.

As a result of COVID-19 and in response to an unfavorable commodity environment, Gevo terminated its production of ethanol and distiller grains in March 2020.  As previously announced, Gevo’s production facility in Luverne, Minnesota (the “Luverne Facility”) is currently producing isobutanol.  During the second half of 2021, Gevo expects to send finished isobutanol from the Luverne Facility to the South Hampton Facility so that renewable premium gasoline or jet fuel can be produced.

Cost of goods sold was $2.8 million for the three months ended June 30, 2021, compared with $2.6 million in the same period in 2020. Cost of goods sold includes $1.6 million associated with the maintenance of the Luverne and South Hampton Facilities and approximately $1.2 million in depreciation expense for the three months ended June 30, 2021.

Gross loss was $2.4 million for the three months ended June 30, 2021, compared with a $1.7 million gross loss in the same period in 2020.

Research and development expense increased by $0.7 million during the three months ended June 30, 2021 compared with the same period in 2020, due primarily to an increase in personnel and consultant expenses as we work to improve our process for growing and fermenting yeast strains.

Selling, general and administrative expense increased by $2.1 million during the three months ended June 30, 2021, compared with the same period in 2020, due primarily to increases in personnel, professional fees and insurance to support the growth in operations and an increase in consulting related to creating our first Environmental, Social and Governance ("ESG") report, which will be released during the third quarter 2021, and documenting our compliance with Section 404(b) of the Sarbanes-Oxley Act.

Preliminary stage project costs increased by $5.3 million during the three months ended June 30, 2021, compared with the same period in 2020, due primarily to increased consulting for preliminary engineering costs, depreciation of the right of use assets related the agreements with the fuel supply and lease agreements and personnel expenses to support the growth in business activity at our Net-Zero projects.

Loss from operations in the three months ended June 30, 2021 was ($19.0) million, compared with a ($5.3) million loss from operations in the same period in 2020.

Non-GAAP cash EBITDA loss in the three months ended June 30, 2021 was ($17.1) million, compared with a ($3.1) million non-GAAP cash EBITDA loss in the same period in 2020.

Interest expense has decreased by $0.5 million in the three months ended June 30, 2021 as compared to the same period in 2020, due to the conversion of all of Gevo’s 12% convertible senior secured notes due 2020/2021 to common stock during 2020.

In the three months ended June 30, 2021, Gevo recognized net non-cash gain totaling less than $0.1 million due to changes in the fair value of certain of its financial instruments, such as warrants.

Gevo incurred a net loss for the three months ended June 30, 2021 of ($18.3) million, compared with a net loss of ($6.0) million during the same period in 2020. Non-GAAP adjusted net loss for the three months ended June 30, 2021 was ($18.3) million, compared with a non-GAAP adjusted net loss of ($5.8) million during the same period in 2020.

Cash, cash equivalents, restricted cash and marketable securities at June 30, 2021 was $567.2 million compared to $525.3 as of the end Q1 2021.

Webcast and Conference Call Information

Hosting today’s conference call at 4:30 p.m. EDT (2:30 p.m. MDT) will be Dr. Patrick R. Gruber, Chief Executive Officer, L. Lynn Smull, Chief Financial Officer, Carolyn M. Romero, Chief Accounting Officer, and Geoffrey T. Williams, Jr., Vice President - General Counsel & Secretary. They will review Gevo’s financial results and provide an update on recent corporate highlights.

To participate in the conference call, please dial 1 (833) 729-4776 (inside the U.S.) or 1 (830) 213-7701 (outside the U.S.) and reference the access code 2267135# or through the event weblink https://edge.media-server.com/mmc/p/8w4ypxhw .

A replay of the call and webcast will be available two hours after the conference call ends on August 12, 2021. To access the replay, please dial 1 (855) 859-2056 (inside the U.S.) or 1 (404) 537-3406 (outside the U.S.) and reference the access code 2267135#. The archived webcast will be available in the Investor Relations section of Gevo’s website at www.gevo.com .

About Gevo

Gevo’s mission is to transform renewable energy and carbon into energy-dense liquid hydrocarbons. These liquid hydrocarbons can be used for drop-in transportation fuels such as gasoline, jet fuel, and diesel fuel, that when burned have potential to yield net-zero greenhouse gas emissions when measured across the full lifecycle of the products. Gevo uses low-carbon renewable resource-based carbohydrates as raw materials, and is in an advanced state of developing renewable electricity and renewable natural gas for use in production processes, resulting in low-carbon fuels with substantially reduced carbon intensity (the level of greenhouse gas emissions compared to standard petroleum fossil-based fuels across their lifecycle). Gevo’s products perform as well or better than traditional fossil-based fuels in infrastructure and engines, but with substantially reduced greenhouse gas emissions. In addition to addressing the problems of fuels, Gevo’s technology also enables certain plastics, such as polyester, to be made with more sustainable ingredients. Gevo’s ability to penetrate the growing low-carbon fuels market depends on the price of oil and the value of abating carbon emissions that would otherwise increase greenhouse gas emissions. Gevo believes that its proven, patented, technology enabling the use of a variety of low-carbon sustainable feedstocks to produce price-competitive low carbon products such as gasoline components, jet fuel, and diesel fuel yields the potential to generate project and corporate returns that justify the build-out of a multi-billion-dollar business.

Gevo believes that Argonne National Laboratory GREET model is the best available standard of scientific based measurement for life cycle inventory or LCI.

Learn more at Gevo’s website: www.gevo.com

Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, including, without limitation, Gevo’s Net-Zero Projects, Gevo’s RNG Project, the engineering and design work for the Net-Zero 1 Project, Gevo’s offtake agreements, Gevo’s plans to develop its business, Gevo’s ability to successfully construct and finance its operations and growth projects, Gevo’s ability to achieve cash flow from its planned projects, the ability of Gevo’s products to contribute to lower greenhouse gas emissions, particulate and sulfur pollution and other statements that are not purely statements of historical fact. These forward-looking statements are made based on the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2020 and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.

Non-GAAP Financial Information

This press release contains financial measures that do not comply with U.S. generally accepted accounting principles (GAAP), including non-GAAP cash EBITDA loss, non-GAAP adjusted net loss and non-GAAP adjusted net loss per share. Non-GAAP cash EBITDA loss excludes depreciation and amortization and non-cash stock-based compensation. Non-GAAP adjusted net loss and adjusted net loss per share excludes non-cash gains and/or losses recognized in the quarter due to the changes in the fair value of certain of Gevo’s financial instruments, such as warrants, convertible debt and embedded derivatives Management believes these measures are useful to supplement its GAAP financial statements with this non-GAAP information because management uses such information internally for its operating, budgeting and financial planning purposes. These non-GAAP financial measures also facilitate management’s internal comparisons to Gevo’s historical performance as well as comparisons to the operating results of other companies. In addition, Gevo believes these non-GAAP financial measures are useful to investors because they allow for greater transparency into the indicators used by management as a basis for its financial and operational decision making. Non-GAAP information is not prepared under a comprehensive set of accounting rules and therefore, should only be read in conjunction with financial information reported under U.S. GAAP when understanding Gevo’s operating performance. A reconciliation between GAAP and non-GAAP financial information is provided in the financial statement tables below.

Cash EBITDA loss is a non-GAAP measure calculated by adding back depreciation and amortization and non-cash stock compensation to GAAP loss from operations. A reconciliation of cash EBITDA loss to GAAP loss from operations is provided in the financial statement tables following this release.

Adjusted net loss per share is a non-GAAP measure calculated by adding back non-cash gains and/or losses recognized in the quarter due to the changes in the fair value of certain of our financial instruments, such as warrants, convertible debt and embedded derivatives, to GAAP net loss per share. A reconciliation of adjusted net loss per share to GAAP net loss per share is provided in the financial statement tables following this release.

Cash EBITDA loss is a non-GAAP measure calculated by adding back depreciation and amortization and non-cash stock compensation to GAAP loss from operations. A reconciliation of cash EBITDA loss to GAAP loss from operations is provided in the financial statement tables following this release.

Adjusted net loss is a non-GAAP measure calculated by adding back non-cash gains and/or losses recognized in the quarter due to the changes in the fair value of certain of our financial instruments, such as warrants, convertible debt and embedded derivatives, to GAAP net loss. A reconciliation of adjusted net loss to GAAP net loss is provided in the financial statement tables following this release.


 

Gevo, Inc.

Condensed Consolidated Balance Sheets Information

(Unaudited, in thousands, except share and per share amounts)

  June 30, 2021   December 31, 2020
Assets          
Current assets          
Cash and cash equivalents $ 17,085     $ 78,338  
Marketable securities (current)   246,886       ?  
Restricted cash (current)   57,645       ?  
Accounts receivable   847       527  
Inventories   2,216       2,491  
Prepaid expenses and other current assets   4,497       1,914  
Total current assets   329,176       83,270  
           
Property, plant and equipment, net   79,243       66,408  
Long-term marketable securities   175,169       ?  
Long-term restricted cash   70,464       ?  
Operating right-of-use asset   1,770       133  
Financing right-of-use asset   27,491       176  
Deposits and other assets   2,361       2,112  


Total assets


$


685,674
   

$


152,099
 
           
Liabilities          
Current liabilities          
Accounts payable and accrued liabilities $ 16,393     $ 3,943  
Operating lease liabilities (current)   ?       172  
Finance lease liabilities (current)   4,888       10  
Loans payable – other (current)   174       807  
Total current liabilities   21,455       4,932  
           
2021 Bonds payable (long-term)   66,120       ?  
Loans payable – other (long-term)   394       447  
Operating lease liabilities (long-term)   1,783       ?  
Financing lease liabilities (long-term)   19,715       162  
Other long-term liabilities   84       179  
Total liabilities   109,551       5,720  
           
Commitments and Contingencies          
           
Stockholders' Equity          
Common Stock, $0.01 par value per share; 250,000,000 authorized,

197,964,476 and 128,138,311 shares issued and outstanding at June

30, 2021 and December 31, 2020, respectively.
  1,980       1,282  
Additional paid-in capital   1,100,932       643,269  
Accumulated other comprehensive loss   (307 )     ?  
Accumulated deficit   (526,482 )     (498,172 )
Total stockholders' equity   576,123       146,379  


Total liabilities and stockholders' equity


$


685,674
   

$


152,099
 
               

Gevo, Inc.

Condensed Consolidated Statements of Operations Information

(Unaudited, in thousands, except share and per share amounts)

  Three Months Ended June 30, Six Months Ended June 30,
    2021       2020       2021       2020  
Revenue and cost of goods sold              
Ethanol sales and related products, net $ ?     $ 83     $ ?     $ 3,783  
Hydrocarbon revenue   346       859       359       984  
Grant and other revenue   76       46       156       46  
Total revenues   422       988       515       4,813  
               
Cost of goods sold   2,794       2,644       4,788       10,783  
               
Gross loss   (2,372 )     (1,656 )     (4,273 )     (5,970 )
               
Operating expenses              
Research and development expense   1,404       677       2,782       1,257  
Selling, general and administrative expense   4,820       2,698       8,692       5,325  
Preliminary stage project costs   5,472       221       8,199       377  
Loss on disposal of assets   4,954       ?       4,954       38  
Restructuring expenses   ?       5       ?       304  
Total operating expenses   16,650       3,601       24,627       7,301  
               
Loss from operations   (19,022 )     (5,257 )     (28,900 )     (13,271 )
               
Other income (expense)              
Gain on forgiveness of SBA loan   641       ?       641       ?  
Interest Expense   (6 )     (541 )     (11 )     (1,086 )
(Loss) on modification of 2020 Notes   ?       (57 )     ?       (726 )
Gain (loss) from change in fair value of derivative warrant liability  



43
     



1
     



(10




)
   



8
 
(Loss) from change in fair value of 2020/21 Notes embedded derivative liability   ?       (176 )     ?       (276 )
Other income (expense)   91       (13 )     (30 )     55  
Total other income (expense), net   769       (786 )     590       (2,025 )
               
Net loss $ (18,253 )   $ (6,043 )   $ (28,310 )   $ (15,296 )
               
Net loss per share - basic and diluted $ (0.09 )   $ (0.40 )   $ (0.15 )   $ (1.04 )
Weighted-average number of common shares outstanding –

basic and diluted
 

198,137,420
      15,071,105       190,892,223       14,771,952  
               

Gevo, Inc.

Condensed Consolidated Statements of Comprehensive Income

(Unaudited, in thousands, except share and per share amounts)

  Three Months Ended June 30, Six Months Ended June 30,
    2021       2020       2021       2020  
               
Net Loss $ (18,253 )   $ (6,043 )   $ (28,310 )   $ (15,296 )
Other comprehensive income (loss)              
Unrealized gains (losses) on available-for-sale securities, net of tax   (307 )     ?       (307 )     ?  
Total change in unrealized gains (losses) on marketable securities   (307 )     ?       (307 )     ?  
               
Comprehensive Loss $ (18,560 )   $ (6,043 )   $ (28,617 )   $ (15,296 )
               

Gevo, Inc.

Condensed Consolidated Statements of Stockholders’ Equity Information

(Unaudited, in thousands, except share amounts)

    Common Stock   Paid-In Capital   Accumulated Other Comprehensive Loss   Accumulated Deficit   Stockholders' Equity
    Shares   Amount        
                                   
  Balance, December 31, 2020 128,138,311     $ 1,282     $ 643,269     $ -     $ (498,172 )   $ 146,379  
                                   
  Issuance of common stock, net of issue costs 68,170,579       682       457,008       -       -       457,690  
  Issuance of common stock upon exercise of warrants 1,863,058       18       1,099       -       -       1,117  
  Non-cash stock-based compensation -       -       562       -       -       562  
  Issuance of common stock under stock plans, net of taxes (121,499 )     (1 )     1       -       -       -  
  Net loss -       -       -       -       (10,057 )     (10,057 )
                                   
  Balance, March 31, 2021 198,050,449       1,981       1,101,939       -       (508,229 )     595,691  
                                   
  Issuance of common stock, net of issue costs -       -       (45 )     -       -       (45 )
  Issuance of common stock upon exercise of warrants 3,700       -       4       -       -       2  
  Non-cash stock-based compensation -       -       858       -       -       858  
  Issuance of common stock under stock plans, net of taxes (89,673 )     (1 )     (1,824 )     -       -       (1,823 )
  Other comprehensive loss -       -       -       (307 )     -       (307 )
  Net loss -       -       -       -       (18,253 )     (18,253 )
                                   
  Balance, June 30, 2021 197,964,476     $ 1,980     $ 1,100,932     $ (307 )   $ (526,482 )   $ 576,123  
                                   
  Balance, December 31, 2019 14,083,232     $ 141     $ 530,349     $ -     $ (457,986 )   $ 72,504  
                                   
  Issuance of common stock, net of issue costs 425,776       4       902       -       -       906  
  Non-cash stock-based compensation -       -       336       -       -       336  
  Issuance of common stock under stock plans, net of taxes 105,882       -       -       -       -       -  
  Net loss -       -       -       -       (9,253 )     (9,253 )
                                   
  Balance, March 31, 2020 14,614,890       145       531,587       -       (467,239 )     64,493  
                                   
  Issuance of common stock, net of issue costs 917,345       9       1,238       -       -       1,247  
  Non-cash stock-based compensation -       -       497       -       -       497  
  Issuance of common stock under stock plans, net of taxes (18,137 )     -       (307 )     -       -       (307 )
  Net loss -       -       -       -       (6,043 )     (6,043 )
                                   
  Balance, June 30, 2020 15,514,098     $ 154     $ 533,015     $ -     $ (473,282 )   $ 59,887  
                                   

 

Gevo, Inc.

Condensed Consolidated Cash Flow Information

(Unaudited, in thousands)

    Three Months Ended June 30, Six Months Ended June 30,
      2021       2020       2021       2020  
Operating Activities                
Net Loss   $ (18,253 )   $ (6,043 )   $ (28,310 )   $ (15,296 )
Adjustments to reconcile net loss to net cash used in

operating activities:
               
Loss (gain) from change in fair value of derivative warrant liability   (43 )     (1 )     10       (8 )
Loss from change in fair value of 2020/21 Notes and 2020 Notes embedded derivative liability     ?       176         ?       276  
Loss on sales of property, plant and equipment     4,954       38       4,954       38  
(Gain) from forgiveness of SBA PPP loans     (641 )     ?       (641 )       ?  
Stock-based compensation     692       501       1,617       673  
Depreciation and amortization     1,223       1,629       2,372       3,278  
Non-cash lease expense     (75 )     14       (58 )     29  
Non-cash interest expense     ?       243       2       393  
Other non-cash expenses     5       ?       5         ?  
Changes in operating assets and liabilities:                
Accounts receivable     (755 )     (594 )     (320 )     389  
Inventories     236       201       275       721  
Prepaid expenses and other current assets, deposits and other assets:     1,131       331       (3,142 )     164  
Accounts payable, accrued expenses and long-term liabilities   (777 )     (338 )     3,768       (1,475 )
Net cash used in operating activities     (12,303 )     (3,843 )     (19,468 )     (10,818 )
                 
Investing Activities                
Acquisitions of property, plant and equipment     (9,537 )     (817 )     (14,167 )     (1,607 )
Purchase of marketable securities     (422,362 )     ?       (422,362 )       ?  
Net cash used in investing activities     (431,899 )     (817 )     (436,529 )     (1,607 )
                 
Financing Activities                
Proceeds from issuance of 2021 Bonds     68,995       ?       68,995         ?  
Debt and equity offering costs     (3,074 )     (63 )     (34,757 )     (115 )
Proceeds from issuance of common stock and common stock warrants   (1,824 )     1,313       487,549       2,271  
Proceeds from the exercise of warrants   2       ?       1,119         ?  
Net settlement of common stock under stock plans   27       (156 )       ?       (310 )
Payments on secured debt     (53 )     (392 )     (53 )     (392 )
Proceeds from SBA loans     ?       1,006         ?       1,006  
Net cash provided by financing activities     64,073       1,708       522,853       2,460  
                 
Net increase (decrease) in cash and cash equivalents     (380,129 )     (2,952 )     66,856       (9,965 )
                 
Cash, cash equivalents, and restricted cash                
Beginning of period     525,323       9,289       78,338       16,302  
                 
End of period   $ 145,194     $ 6,337     $ 145,194     $ 6,337  
                 

Gevo, Inc.

Reconciliation of GAAP to Non-GAAP Financial Information

(Unaudited, in thousands, except share and per share amounts)

  Three Months Ended June 30,   Six Months Ended June 30,
Non-GAAP Cash EBITDA   2021       2020       2021       2020  
               
Loss from operations $ (19,022 )   $ (5,257 )   $ (28,900 )   $ (13,271 )
Depreciation and amortization   1,223       1,629       2,372       3,278  
Stock-based compensation   692       501       1,617       673  
Non-GAAP cash EBITDA $ (17,107 )   $ (3,127 )   $ (24,911 )   $ (9,320 )
               
Non-GAAP Adjusted Net Loss              
               
Net Loss $ (18,253 )   $ (6,043 )   $ (28,310 )   $ (15,296 )
Adjustments:              
(Loss) on modification of 2020 Notes   ?       (57 )     ?       (726 )
Gain (loss) from change in fair value of derivative warrant liability   43       1       (10 )     8  
(Loss) from change in fair value of 2020/21 Notes and 2020 Notes embedded derivative liability   ?       (176 )     ?       (276 )
Total adjustments   43       (232 )     (10 )     (994 )


Non-GAAP Net Income (Loss)
$ (18,296 )   $ (5,811 )   $ (28,300 )   $ (14,302 )
Non-GAAP adjusted net loss per share -

basic and diluted
$ (0.09 )   $ (0.39 )   $ (0.15 )   $ (0.97 )
Weighted-average number of common

shares outstanding - basic and diluted
  198,137,420       15,071,105       190,892,223       14,771,952  

Investor and Media Contact

+1 720-647-9605

IR@gevo.com



Company Ticker Price Previous Mkt Cap Volume 52wk Range
Gevo Inc.
GEVO (Nasdaq)
$4.71
$4.80 (-1.87%)
$951.37M
0
$2.79 - $9.64
Fundamental Analysis
Rating Outperform
NEWS Channel
  Musk Refiles with SEC Changing Status to Active Investor in Twitter, 04/06/2022
  Release - Tonix Pharmaceuticals Announces Extension of Sponsored Research Agreement with Kansas State University, 04/06/2022
  Bitcoin Energy Use Could be Slashed Significantly, 04/06/2022
  Release - Tonix Pharmaceuticals Announces IND Clearance for TNX-102 SL, 04/06/2022
  The Appeal of EVs with Bidirectional Charging, 04/05/2022
  Two-Time Stanley Cup Champion Shares Plans For Next Goal at NobleCon18, 04/05/2022
  Release - Defense Metals Closes Private Placement Financing, 04/05/2022
  Release - Maple Gold Reports Fall 2021 Drill Results at Douay, 04/05/2022
  Release - Voyager Provides Update on State Orders, 04/05/2022
  The SEC Wants to Extend Investor Protections to Crypto Platforms, 04/05/2022
  Release - electroCore Announces Exclusive License Agreement with Teijin for Japan Territory, 04/05/2022
  Release - Flotek Industries Regains Compliance With NYSEs Continued Listing Standard, 04/05/2022
  Should Accountants Investment Advisors and Lawyers Move to the Metaverse, 04/04/2022
  Release - Allegiant Announces Commencement and Expansion of Drilling Program at Eastside, 04/04/2022
  Release - Voyager Digital Announces Participation In April Investor Events, 04/04/2022
  Prosthetic Touch Signal Back to the Brain Hits a Glitch, 04/04/2022
  House Overwhelmingly Passes Changes to Retirement Savings, 04/02/2022
  Release - Schwazze Announces Fourth Quarter Full Year 2021 Results, 04/01/2022
  Q1 Record-Breaking Crypto Theft, 04/01/2022
  How Big is the News in the Telomere-to-Telomere Reports, 04/01/2022
  Release - PDS Biotech Provides Business Update and Reports Fourth-Quarter and Full-Year 2021 Financial Results, 03/31/2022
  Release - Gray Sets Date For First Quarter Earnings Release And Earnings Conference Call, 03/31/2022
  Release - Kratos Demonstrates All-Digital Multi-Mission Edge Capability at the 37th Space Symposium, 03/31/2022
  Wendyverse Allows Wendys to Meta Market, 03/31/2022
  Forecasting Stocks Disease Weather Sales All Made Easier With a Simple Algorithm, 03/31/2022
  TV and Radio Personalities to Moderate Panels at NobleCon18, 03/31/2022
  Release - CanAlaska - Waterbury South Uranium Targets Extended in Latest Winter Drill Program, 03/31/2022
  What is the PCE Price Index (In 500 Words or Less), 03/31/2022
  What is a Stock Split, 03/30/2022
  Robinhood Launching Extended Hours, 03/30/2022
  The Yield Curve as a Leading Indicator Has Been Compromised, 03/30/2022
  Release - QuoteMedia Announces 22 Revenue Growth for 2021, 03/30/2022
  Release - Cypress Development Announces Results From Its Lithium Extraction Pilot Plant In Nevada, 03/30/2022
  Release - Voyager News Release 20220330, 03/30/2022
  Are Economic Excesses Creating Investment Opportunity, 03/30/2022
  Release - Ayala Pharmaceuticals Reports Full-Year 2021 Financial Results and Provides Corporate Update, 03/29/2022
  Release - Flotek Announces Earnings Schedule For 2021 Results, 03/29/2022
  Release - Comstock Announces Full Year 2021 Results, 03/29/2022
  For Retail Investors AMCs CEO Adam Aron May Have Been the Biggest Star at the Oscars, 03/29/2022
  Release - BioSig Technologies Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services, 03/29/2022
  Release - ISG Acquires AI Platform Solution Agreemint, 03/29/2022
  Regulators May Add New Guard Rails to Temper Investment Risk, 03/29/2022
  Release - Genco Shipping Trading Limited to Participate in Capital Links 16th Annual International Shipping Forum, 03/28/2022
  Release - Motorsport Games rFactor 2 Becomes The Official Sim Racing Platform Of Formula E, 03/28/2022
  Zuckerberg Top Executive Joins NobleCon18 Lineup, 03/28/2022
  Will the Chinese Yuan Disrupt US Dollar Investments and Cause Inflation, 03/28/2022
  Release - Comtech Telecommunications Corp. Responds to Aid Request from The Ukrainian Government, 03/28/2022
  Release - QuoteMedia Year End 2021 Financial Results and Investors Conference Call March 30 2022, 03/28/2022
  The Surprising Ways that Food Prices are Impacted by Oil Prices, 03/28/2022
  Precious Metals Seem to be Ignoring the Feds Message, 03/26/2022
  Marijuana Hits the House This Spring, 03/25/2022
  Release - Motorsport Games Partners With Romain Grosjean To Assist In The Development Of rFactor 2 And Esports Events, 03/25/2022
  Release - Filament Health Announces Second Patent Issuance, 03/25/2022
  This SPAC Took a Different Track Which May Open Doors for Others, 03/25/2022
  Detailed Data Sharing Plans for Medical Research are Soon Due, 03/25/2022
  Release - Comstock Announces 2022 Annual Meeting, 03/24/2022
  Release - Neovasc Announces Consolidation and Extension of Convertible Debt, 03/24/2022
  Release - ProMIS Neurosciences to Present at the 10th Annual Neurodegenerative Drug Development Summit, 03/24/2022
  Enough US Produced Lithium to Exceed Today’s Demand, 03/24/2022
  What is the Yield Curve, 03/24/2022
  Unraveling Stem Cells Secrets, 03/24/2022
  Release - BioSig Announces Closing of Public Offering of Common Stock, 03/23/2022
  NobleCon18 Presenting Companies, 03/23/2022
  Release - Ocugen Announces Appointment Of Marna C. Whittington PhD To Board Of Directors, 03/23/2022
  Taxpayer-Funded Study on Cannabis and Chronic Pain, 03/23/2022
  Release - PDS Biotechnology Reschedules 2021 Fourth Quarter and Full Year Financial Results and Conference Call, 03/23/2022
  Release - Onconova Therapeutics To Present At The Next Generation Kinase Inhibitors Summit, 03/23/2022
  Release - electroCore Announces Dr. Peter Staats to Keynote the Fifth Annual Bioelectronic Medicine Forum in New York, 03/23/2022
  SEC Climate Change Disclosure Rules and Challenges, 03/23/2022
  Release - Digerati Technologies Inc. to present at NobleCon18 - Hard Rock Guitar Hotel Miami - April 20 21, 03/23/2022
  Release - PsyBio Therapeutics to Participate in the 2022 Maxim Group Virtual Growth Conference on March 28-30 2022, 03/23/2022
  Release -Cocrystal Pharma Reports 2021 Financial Results and Provides Updates on Development Programs and Milestones, 03/23/2022
  Release - BioSig Technologies Inc. Announces $3 Million Financing with Family Office, 03/22/2022
  Release - Cocrystal Pharma to Participate in the Maxim Group 2022 Virtual Growth Conference, 03/22/2022
  Release - Comstock Announces Notice of 2021 Year End Webcast, 03/22/2022
  Release - Tonix Pharmaceuticals to Participate in the 2022 Virtual Growth Conference, 03/22/2022
  Bitcoin ETFs Again Experience Extreme Caution from SEC, 03/22/2022
  Release - Delta Air Lines Signs 75 Million Gallon Per Year Agreement with Gevo, 03/22/2022
  Release - electroCore to Present at 2022 Maxim Virtual Growth Conference, 03/22/2022
  Release - Endeavour Silver Closes US$46 Million Bought Deal Financing Including US$6 Million Over-Allotment Option Exercise in Full, 03/22/2022
  The Case for More US Produced Uranium, 03/22/2022
  Release - Tonix Pharmaceuticals Announces Phase 3 RALLY Study Results for TNX-102 SL 5.6 mg for the Management of Fibromyalgia, 03/21/2022
  Release - Lineage Announces Pipeline Expansion To Include Auditory Neuronal Cell Therapy For Treatment Of Hearing Loss, 03/21/2022
  Release - Allegiant Amends Option Agreement And Announces Work Program At Goldfield West, 03/21/2022
  Release - Chakana Copper to Participate at Swiss Mining Institute Virtual Conference, 03/21/2022
  The Metaverse is Under Construction Here’s What is Known, 03/21/2022
  Mapping Psilocybins Effect on the Brain, 03/21/2022
  Release - Salem Media Announces Promotion of Bill Long, 03/21/2022
  Release - Item 9 Labs Corp. to Acquire The Herbal Cure in Denver, Colorado, 03/18/2022
  Release - Alvopetro Announces 33 Increase In Quarterly Dividend To US$0.08 Per Share Year-End 2021 Financial Results, 03/18/2022
  Release - Schwazze Announces Listing Of Common Shares On The NEO Exchange Under The Symbol SHWZ, 03/18/2022
  Is Cathie Woods Innovation Fund Getting a ReBoot, 03/18/2022
  The Feds Fight Against Raging Inflation is a Process, 03/18/2022
  Release - Maple Gold Reports Updated Douay Mineral Resource Estimate Indicated Resources Increase, 03/18/2022
  Quantifying the Pandemics Impact on Disposition, 03/18/2022
  Release - ProMIS Neurosciences Announces Fiscal Year 2021 Results, 03/17/2022
  Release - Sierra Metals Reports 2021 Consolidated Financial Results And Announces 2022 Guidance, 03/17/2022
  Release - Element79 Gold to Provide Further Insight and Analysis on High-Grade Peruvian Gold Portfolio, 03/17/2022
  AMC Theatres CEO Calls Gold Mining Investment Truly Terrific Opportunity, 03/17/2022
  Has Uranium Demand Changed with Russia Ukraine War?, 03/17/2022
  Release - BioSig Technologies Inc. Appoints John Sieckhaus as Chief Operating Officer, 03/16/2022
  What is Fed Tightening, 03/16/2022
  Release -Schwazze Signs Definitive Documents To Acquire Assets Of Urban Health Wellness Inc., 03/16/2022
  FenixOro Plans Production of Special Edition Gold Coins Mined from Abriaqui, 03/16/2022
  Release - InPlay Oil Corp. Announces Record Setting 2021 Financial Operating and Reserves Results, 03/16/2022
  Release - Energy Fuels Announces 2021 Results, 03/16/2022
  Doubling Down on Stocks Advancing, 03/16/2022
  Generating Synthetic Data to Speed AI, 03/16/2022
  Release - Department of Defense Selects Vectrus for Development of 5G Smart Warehouse, 03/16/2022
  Release - ACCO Brands Announces Deborah A. O’Connor as Chief Financial Officer, 03/15/2022
  Release - PDS Biotech Announces Achievement of an Enrollment Objective in National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination, 03/15/2022
  Release - PsyBio Therapeutics Announces Proposed Acquisition of Everest Pharma Pty Ltd, 03/15/2022
  Tighter But Still Easy Money, 03/15/2022
  Metaverse Vacations are Latest Use of this Technology, 03/15/2022
  Release - Allegiant Gold Announces A C$4.0 Million Strategic Investment By Kinross Gold Corporation For Exploration At The Eastside Property, 03/14/2022
  Release - Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights, 03/14/2022
  Genetically Modifying Pigs Organs Could offset Transplant Demand, 03/14/2022
  Why Web3 is a True Collaboration Between Young and Old, 03/14/2022
  A Global Reimagined Health Ecosystem, 03/11/2022
  New York Marijuana Seeding Opportunity Initiative is One-of-a-kind, 03/11/2022
  News Addiction Can it be Measured?, 03/11/2022
  The Melt Value of a Nickel Coin, 03/10/2022
  Release - Comstock Releases Shareholder Letter 20220310, 03/10/2022
  A Look at NFTs Past and Future One Year After Beeple Sale, 03/10/2022
  Release - Cocrystal Pharma Initiates Enrollment in Phase 1 Influenza A Study with CC-42344, 03/10/2022
  Release - Defense Metals Corp. Drills 2.50 Total Rare Earth Oxide Over 176 Metres, 03/10/2022
  Release - TherapeuticsMD Announces Fourth Quarter 2021 Financial Results, 03/10/2022
  ESG Policies and Corporate Departures from Russia, 03/10/2022
  Seanergy Maritime Holdings Corp. Reports Record Fourth Quarter 2021 Financial Results, 03/10/2022
  Release - Ceapro Signs Exclusive Long-Term Supply and Distribution Agreement with Symrise, 03/10/2022
  Release - Tonix Pharmaceuticals Announces Appointment of Jeffrey Rosenfeld PhD, 03/09/2022
  Li-Ion Batteries Promising New Process, 03/09/2022
  Release - Ayala Pharmaceuticals to Present at the 32nd Annual Oppenheimer Healthcare Conference, 03/09/2022
  Release - Lifeist Portfolio Company Mikra Begins Presales of CELLF, 03/09/2022
  Release - PDS Biotechnology Announces Conference Call and Webcast for Fourth Quarter and Full Year 2021 Financial Results, 03/09/2022
  Release - electroCore Announces Changes to its Board of Directors, 03/09/2022
  Digital Currencies Gain Value on Biden Executive Order, 03/09/2022
  Release - Item 9 Labs Corp. Launches Reg A Public Offering Keep Cannabis Local Campaign, 03/09/2022
  Release - Avivagen Secures New Influential Customer in Mexico, 03/08/2022
  NobleCon18 - Noble Capital Markets 18th Annual Investor Conference, 03/08/2022
  Release - Defense Metals Corp. Continues to Drill High Grade at Wicheeda, 03/08/2022
  Release - Alvopetro Announces 2021 Year End Reserves With a 52 Increase In 2P NPV Before Tax, 03/08/2022
  Can Icahn and Buffett Both be Right on Occidental Petroleum, 03/08/2022
  EV Inflation Outpacing Traditional Cars, 03/08/2022
  Release - Vectrus Announces Fourth Quarter and Full-Year 2021 Results, 03/07/2022
  Release - Vectrus and Vertex to Combine Creating a Global Leader in Mission-Essential Solutions, 03/07/2022
  Release - Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital, 03/07/2022
  Release - TherapeuticsMD Enters Into a Definitive Agreement to Divest vitaCare to GoodRx, 03/07/2022
  Release - Comtech Partners with RapidSOS to Provide Life-Saving Data to 911 Agencies Across the United States, 03/07/2022
  Crude Talk from Cathie Wood as She Remains Positive on Need for Innovation, 03/07/2022
  Release - Salem Media Group Inc. Schedules 2022 Annual Meeting of Stockholders, 03/07/2022
  Collaborating With Robots, 03/07/2022
  Integrating Innovative Technology Inputs in Modern Warfare, 03/04/2022
  Release - Lifeist Wellness to Release Fourth Quarter and Full Year 2021 Results on March 25 2022, 03/04/2022
  Release - Sierra Metals Announces Filing Of NI 43-101 Technical Report For Updated PEA On The Expansion Of Its Yauricocha Mine In Peru, 03/04/2022
  Release - Item 9 Labs Corp. Closes Acquisition of Adams County Colorado Dispensary, 03/04/2022
  Nancy Pelosis Coattail Investors Get an Update, 03/04/2022
  Release - Ocugen Provides an Update on its COVAXIN Pediatric 2-18 Emergency Use Authorization EUA Request, 03/04/2022
  Kleptocapture and its Targets, 03/04/2022
  Release - Cocrystal Pharma to Participate in Upcoming Investment Conferences, 03/03/2022
  Release - electroCore to Announce Fourth Quarter and Year Ended December 31, 2021 Financial Results, 03/03/2022
  Release - Seanergy Maritime Sets Date for the Fourth Quarter and Twelve Months Ended December 31 2021 Financial Results, 03/03/2022
  Release - Orion Group Holdings Inc. Reports Fourth Quarter and Full Year 2021 Results, 03/03/2022
  Should Bitcoins Ability to Soften Sanctions and Stabilize Russian Finances be Stopped, 03/03/2022
  Crisis and Stock Market Price Patterns, 03/03/2022
  Release - Defense Metals Drills 3.17 Total Rare Earth Oxide Over 196 Metres From Surface, 03/02/2022
  Release - Ceapro Bolsters Board of Directors with Appointment of Top Executive from Global Pharmaceutical Industry, 03/02/2022
  Release - ProMIS Neurosciences PMN310 antibody demonstrates significant cognitive benefit in a mouse model of Alzheimers disease, 03/02/2022
  Release - Seanergy Announces New Refinancing Facility of $21.3 million with a Prominent Japanese Lender, 03/02/2022
  Strategic Oil Reserves Put in Play, 03/02/2022
  Release - Item 9 Labs Corp Strengthens Board of Directors with Appointment of Massage Heights Founder, 03/02/2022
  Economists Waiting for the Other Shoe to Drop, 03/02/2022
  Release - FenixOro Provides Commentary on Colombian Amendment to Second Law, 03/01/2022
  Release - Voyager Digital Announces Participation In March Investor Events, 03/01/2022
  Release - Lineage Cell Therapeutics To Report Fourth Quarter And Full Year 2021 Financial Results, 03/01/2022
  Release - Gray Names Lorri Mcclain To Its Board Of Directors, 03/01/2022
  Release - Entravision Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call, 03/01/2022
  Russia Ukraine War and Reliance on Crypto and Blockchain, 03/01/2022
  The U.S. Gets Its First State of the Union in Two Years Much Has Changed, 03/01/2022
  Release - Salem Podcast Network Announces New Podcast with Dennis Prager and Julie Hartman, 02/28/2022
  Two Ways Artificial Intelligence is Helping Cybersecurity, 02/28/2022
  Scheduled Speakers NobleCon18, 02/28/2022
  The SPAC Advantage in a Volatile or Bear Market, 02/28/2022